Back
Context Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
CNTX
Context Therapeutics
Last Price:
1.39
Seasonality Move:
-30%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNTX is experiencing slight buying pressure.
Context Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.7 | Sell |
| 20-day SMA: | 1.98 | Sell |
| 50-day SMA: | 2 | Sell |
| 200-day SMA: | 1.83 | Sell |
| 8-day EMA: | 1.66 | Sell |
| 20-day EMA: | 1.86 | Sell |
| 50-day EMA: | 2 | Sell |
| 200-day EMA: | 1.85 | Sell |
Context Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 23.23 | Sell |
| Chaikin Money Flow: | 392487 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 2.29) | Sell |
| Bollinger Bands (100): | (1.89 - 2.39) | Sell |
Context Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Context Therapeutics Stock
Is Context Therapeutics Stock a Buy?
- Context Therapeutics share price is 1.39 while CNTX 8-day simple moving average is 1.70, which is a Sell signal.
- The stock price of CNTX is 1.39 while Context Therapeutics 20-day SMA is 1.98, which makes it a Sell.
- Context Therapeutics 50-day simple moving average is 2.00 while CNTX share price is 1.39, making it a Sell technically.
- CNTX stock price is 1.39 and Context Therapeutics 200-day simple moving average is 1.83, creating a Sell signal.
CNTX Technical Analysis vs Fundamental Analysis
Sell
10
Context Therapeutics (CNTX)
is a Sell
Is Context Therapeutics a Buy or a Sell?
-
Context Therapeutics stock is rated a Sell
The current Context Therapeutics [CNTX] share price is $1.39. The Score for CNTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Context Therapeutics Stock Info
Market Cap:
104.25M
Price in USD:
1.39
Share Volume:
784.97K
Context Therapeutics 52-Week Range
52-Week High:
2.75
52-Week Low:
0.77
Sell
10
Context Therapeutics (CNTX)
is a Sell
Context Therapeutics Share Price Forecast
-
What is the Context Therapeutics stock price today?
The Context Therapeutics stock price is 1.39 USD today. -
Will CNTX stock go up or go down?
Context Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Context Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Context Therapeutics is overvalued.
Is Context Therapeutics Stock a Buy?
- Context Therapeutics share price is 1.39 while CNTX 8-day exponential moving average is 1.66, which is a Sell signal.
- The stock price of CNTX is 1.39 while Context Therapeutics 20-day EMA is 1.86, which makes it a Sell.
- Context Therapeutics 50-day exponential moving average is 2.00 while CNTX share price is 1.39, making it a Sell technically.
- CNTX stock price is 1.39 and Context Therapeutics 200-day simple moving average is 1.85, creating a Sell signal.
Fundamental Analysis of Context Therapeutics
Is Context Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.21 per share.
Technical Analysis of Context Therapeutics
Should I short Context Therapeutics stock?
- CNTX Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Context Therapeutics is a Sell
- Context Therapeutics Relative Strength Index (RSI) is 23.23, which suggest Context Therapeutics is oversold
- The Bollinger Bands (25) for Context Therapeutics is (1.75 - 2.29), which suggest Context Therapeutics is a Sell
- The Bollinger Bands (100) for Context Therapeutics is (1.89 - 2.39), which suggest Context Therapeutics is a Sell
* Context Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.